Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
Todd D. Levine
,
Alan Pestronk
Department of Neurology
Institute of Clinical and Translational Sciences (ICTS)
Section of Neuromuscular Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
244
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
B Cells
100%
Chemotherapy
100%
Rituximab
100%
GM1 Ganglioside
100%
Polyneuropathy
100%
B-cell Depletion
100%
IgM Antibody
100%
Monoclonal Antibody
50%
Cell Surface
50%
Glycoprotein
50%
Titer
50%
Autoantibodies
50%
Current Treatment
50%
Neuropathy
50%
Strength Measurement
50%
Surface Membrane
50%
CD20
50%
Improved Function
50%
Antibody-associated
50%
Immunoglobulin M Antibody
50%
Membrane Markers
50%
Anti-GM1
50%
Neuroscience
B Cell
100%
Polyneuropathy
100%
Rituximab
100%
Immunoglobulin M Antibody
100%
Ganglioside GM1
66%
Monoclonal Antibody
33%
Autoantibodies
33%
Glycoprotein
33%
CD20
33%
Membrane Marker
33%
Neuropathy
33%